Decreased neutrophil extracellular trap degradation in shiga toxin-associated haemolytic uraemic syndrome

Journal of Innate Immunity

Volumn 9, Issue 1, 2017, Pages 12-21

  Leffler, Jonatan ^a,b   Prohászka, Zoltán ^c   Mikes, Bálint ^c   Sinkovits, György ^c   Ciacma, Katarzyna ^a   Farkas, Péter ^c   Réti, Marienn ^e   Kelen, Kata ^d   Reusz, György S ^d   Szabó, Attila J ^d   Martin, Myriam ^a   Blom, Anna M ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c Third Department of Medicine   (Czech Republic)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e Szent Laszlo Hospital   (Hungary)

Author keywords

Degradation; Kidney injury; Neutrophil extracellular traps; Nuclease activity; Shiga toxin associated haemolytic uraemic syndrome; Thrombotic microangiopathies

Indexed keywords

CREATININE; DOUBLE STRANDED DNA; NUCLEASE; SHIGA TOXIN; DEOXYRIBONUCLEASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR TRAP; FEMALE; FOLLOW UP; HEMOLYTIC UREMIC SYNDROME; HUMAN; HUMAN CELL; INFANT; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEWBORN; THROMBOTIC THROMBOCYTOPENIC PURPURA; CELL CULTURE; IMMUNOLOGY; LEUKOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; NEUTROPHIL; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEOXYRIBONUCLEASES; EXTRACELLULAR TRAPS; FEMALE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFANT; MALE; MIDDLE AGED; NEUTROPHIL ACTIVATION; NEUTROPHILS; SHIGA TOXIN; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 84992694408     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000450609     Document Type: Article

References (32)

1. Shenkman B, Einav Y: Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification. Autoimmun Rev 2014; 13: 584-586.
2. Scheiring J, Andreoli SP, Zimmerhackl LB: Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 2008; 23: 1749-1760.
3. Sandvig K: Shiga toxins. Toxicon 2001; 39: 1629-1635.
4. Nester CM, Barbour T, de Cordoba SR, Dragon-Durey MA, Fremeaux-Bacchi V, Goodship TH, Kavanagh D, Noris M, Pickering M, Sanchez-Corral P, Skerka C, Zipfel P, Smith RJ: Atypical aHUS: state of the art. Mol Immunol 2015; 67: 31-42.
5. George JN, Charania RS: Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. Semin Thromb Hemost 2013; 39: 153-160.
6. George JN, Terrell DR, Vesely SK, Kremer Hovinga JA, Lammle B: Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med 2012; 41:e177-e188.
7. Scully M, Goodship T: How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome. Br J Haematol 2014; 164: 759-766.
8. Fuchs TA, Kremer Hovinga JA, Schatzberg D, Wagner DD, Lammle B: Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies. Blood 2012; 120: 1157-1164.
9. Mikes B, Sinkovits G, Farkas P, Csuka D, Schlammadinger A, Razso K, Demeter J, Domjan G, Reti M, Prohaszka Z: Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura. Thromb Res 2014; 133: 616-621.
10. Jimenez-Alcazar M, Napirei M, Panda R, Kohler EC, Kremer Hovinga JA, Mannherz HG, Peine S, Renne T, Lammle B, Fuchs TA: Impaired DNase1-mediated degradation of neutrophil extracellular traps is associated with acute thrombotic microangiopathies. J Thromb Haemost 2015; 13: 732-742.
11. Ramos MV, Mejias MP, Sabbione F, Fernandez-Brando RJ, Santiago AP, Amaral MM, Exeni R, Trevani AS, Palermo MS: Induction of neutrophil extracellular traps in Shiga toxin-associated hemolytic uremic syndrome. J Innate Immun 2016; 8: 400-411.
12. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A: Neutrophil extracellular traps kill bacteria. Science 2004; 303: 1532-1535.
13. Bjornsdottir H, Welin A, Michaelsson E, Osla V, Berg S, Christenson K, Sundqvist M, Dahlgren C, Karlsson A, Bylund J: Neutrophil net formation is regulated from the inside by myeloperoxidase-processed reactive oxygen species. Free Radic Biol Med 2015; 89: 1024-1035.
14. Knight JS, Kaplan MJ: Lupus neutrophils: 'NET' gain in understanding lupus pathogenesis. Curr Opin Rheumatol 2012; 24: 441-450.
15. Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A: Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 2010; 107: 9813-9818.
16. Leffler J, Ciacma K, Gullstrand B, Bengtsson AA, Martin M, Blom AM: A subset of patients with systemic lupus erythematosus fails to degrade DNA from multiple clinically relevant sources. Arthritis Res Ther 2015; 17: 205.
17. Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, Rubin CJ, Zhao W, Olsen SH, Klinker M, Shealy D, Denny MF, Plumas J, Chaperot L, Kretzler M, Bruce AT, Kaplan MJ: Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol 2011; 187: 538-552.
18. Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A: Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp 2010:e1724.
19. Leffler J, Martin M, Gullstrand B, Tyden H, Lood C, Truedsson L, Bengtsson AA, Blom AM: Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease. J Immunol 2012; 188: 3522-3531.
20. Szarvas N, Szilagyi A, Csuka D, Takacs B, Rusai K, Muller T, Arbeiter K, Reti M, Haris A, Wagner L, Torok S, Kelen K, Szabo AJ, Reusz GS, Morgan BP, Prohaszka Z: Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome. Mol Immunol 2016; 71: 10-22.
21. Shiokawa D, Tanuma S: Characterization of human DNase I family endonucleases and activation of DNase gamma during apoptosis. Biochemistry 2001; 40: 143-152.
22. Yoshida M, Sasaki M, Sugisaki K, Yamaguchi Y, Yamada M: Neutrophil extracellular trap components in fibrinoid necrosis of the kidney with myeloperoxidase-ANCA-associated vasculitis. Clin Kidney J 2013; 6: 308-312.
23. Lazarides E, Lindberg U: Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc Natl Acad Sci USA 1974; 71: 4742-4746.
24. Fuchs TA, Brill A, Wagner DD: Neutrophil extracellular trap (NET) impact on deep vein thrombosis. Arterioscler Thromb Vasc Biol 2012; 32: 1777-1783.
25. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, Patel KD, Chakrabarti S, McAvoy E, Sinclair GD, Keys EM, Allen-Vercoe E, Devinney R, Doig CJ, Green FH, Kubes P: Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med 2007; 13: 463-469.
26. von Bruhl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, Khandoga A, Tirniceriu A, Coletti R, Kollnberger M, Byrne RA, Laitinen I, Walch A, Brill A, Pfeiler S, Manukyan D, Braun S, Lange P, Riegger J, Ware J, Eckart A, Haidari S, Rudelius M, Schulz C, Echtler K, Brinkmann V, Schwaiger M, Preissner KT, Wagner DD, Mackman N, Engelmann B, Massberg S: Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med 2012; 209: 819-835.
27. Kambas K, Mitroulis I, Apostolidou E, Girod A, Chrysanthopoulou A, Pneumatikos I, Skendros P, Kourtzelis I, Koffa M, Kotsianidis I, Ritis K: Autophagy mediates the delivery of thrombogenic tissue factor to neutrophil extracellular traps in human sepsis. PLoS One 2012; 7:e45427.
28. Wang H, Wang C, Zhao MH, Chen M: Neutrophil extracellular traps can activate alternative complement pathways. Clin Exp Immunol 2015; 181: 518-527.
29. Morigi M, Galbusera M, Gastoldi S, Locatelli M, Buelli S, Pezzotta A, Pagani C, Noris M, Gobbi M, Stravalaci M, Rottoli D, Tedesco F, Remuzzi G, Zoja C: Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis. J Immunol 2011; 187: 172-180.
30. Stahl AL, Sartz L, Karpman D: Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome. Blood 2011; 117: 5503-5513.
31. Locatelli M, Buelli S, Pezzotta A, Corna D, Perico L, Tomasoni S, Rottoli D, Rizzo P, Conti D, Thurman JM, Remuzzi G, Zoja C, Morigi M: Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement. J Am Soc Nephrol 2014; 25: 1786-1798.
32. Zykova SN, Tveita AA, Rekvig OP: Renal DNase1 enzyme activity and protein expression is selectively shut down in murine and human membranoproliferative lupus nephritis. PLoS One 2010;5:e12096.